تقدير مستوى ACE-2 وبعض المعلمات البيوكيميائية مع دراسة ثاثيره الجنس على مرضى السكري العراقين المصابين بتليف الكبيبات والنبيبات الكلوية كعلامة للتنبؤ المبكر

Zainab A Salman, Kadhim K Ghudhaib, Raghad Fadhil. Evaluating osteocalcin and ostenectin in serum male patients with type 2 diabetes mellitus and periodontitis. Eurasian Chem Commun. 2022; 16 (4): 295-302. https://dx.doi.org/10.22034/ecc.2022.325049.1307

Zainab A, Salman, Kadhim K Ghudhaib, Raghad Fadhil. Association of osteopontin and alkaline phosphatase in male patients with diabetes mellitus type 2 and periodontitis. Iran J War Public Health. 2022; 14(1): 105-109. https://dx.doi.org/10.30526/36.1.2924

Sabreen Ali Muzil, Kadhim K Ghudhaib, Ali Abdulmajid Dyab Allawi. Evaluation of pentraxin3 level in Iraqi patients with diabetic nephropathy. Biochem Cell Arch. 2018; 18(2): 2479-2482.

Sabreen Ali Muzil, Ali Abdulmajid Dyab Allawi, Kadhim K Ghudhaib. Determination of TNF1 level and its association with ACR and eGFR in Iraqi patients with different stages of diabetic nephropathy. Journal of Global Pharma Technology. 2018; 10 (05): 449-454.

Ghada salam Hamed, Kadhim K Ghudhaib, Ali A Allawi. Association of type IV collagen with progression of diabetic nephropathy disease in Iraqi patients under typical criteria. Arch. 2021; 21(1): 1471-1475.

Ghada Salam Hamid, Ali A Allawi, Kadhim K Ghudhaib. Correlation of Pentosidine with Kidney Diseases in Iraqi Patients with Diabetic Nephropathy. Iraqi J Sci. 2021; 30: 3436-42. https://dx.doi.org/10.24996/ijs.2021.62.10.2

Wahaj Sinan Mohammed, Kadhim K Ghudhaib, Ali A Allawi. Evaluation of Glomerular Disorder in Diabetic Patients with Nephropathy. Biochem Cell Arch. 2022; 22 (1): 963-969. https://dx.doi.org/10.3390/

jcm10091855

Kadhim K Ghudhaib, Firas Younis Mohsen, Hind Sadiq Mohammed. Evaluation of Antioxidant Levels in Blood Sera of Iraqi Patients with T2DM. J Glob Pharma Technol. 2018; 10(3-4): 895-899

Hind Sadiq Mohammed, Kadhim K Ghudhaib, Firas Younis Mohsen. Estimation of enzymatic and non-enzymatic antioxidants in sera of Iraqi patients with sensory neuropathy. Biochem Cell Arch. 2018; 1 (18): 1011-1016. .

Tuka J, Khazeil, Kadhim K Ghudhaib, Firas Y. Mohsen. Assessment of levels of netrin-1 and adipsin in patients with diabetic peripheral neuropathy. Biochem Cell Arch. 2020; 20 (2): 6027-6032. DOI Zina J Ghaib, Kadhim K Ghudhiab, Firas Y. Mohsen. Assessment of Neuron Specific Enolase Level and some Related Biochemical Factors in Patients with Diabetic Peripheral Nerve Disorders. J Forensic Med Toxicol. 2021; 15 (3):1494-1500. https://dx.doi.org/10.37506/ijfmt.v15i3.15515

Marwa Nazar, Kadhim K. Ghudhaib, Firas Y. Mohsen. Evaluation of Nerve Growth Factor, Fetuin A and Adiponectin Levels in Diabetic Patients with Sensory Neuropathy. N L M. 2021; 10(1): 4103-4117.

Kadhim K Ghudhaib, Kismat, M.Turaki, Sabreen A Muzal. Estimation of Serum Osteocalcin Levels in Osteoporotic Postmenopausal Women with Type 2 Diabetes Mellitus. Iraqi J Sci. 2014 Sep-; 11 (4):1549-1555. https://dx.doi.org/10.1016/j.dsx.2018.04.035

Ghudhaib K, Turki K, Mezel S, Alzedi G, Alosami M. Association of Serum Adiponectin with Serum Insulin and Body mass density (BMD) in postmenopausal Osteoporotic women with and without T2DM. IOSR J Appl Chem. 2014; 7 (5): 119-122.. https://dx.doi.org/10.9790/5736-0752119122

Kadhim K Ghudhaib. Effect of alcoholic catechin extract on hyperglycemia, hyperlipidemia and liver functions in alloxan –diabetic mice. Iraqi J Sci. 2014;11(3):1192-200. https://dx.doi.org/10.21123/bsj.2014.11.3.1192-1200

Kadhim K Ghudhaib. Evaluation of Ginger Rhizomes Extract Effect on Glucose Level, Lipid Profile and Liver Function in Induced Alloxan Diabetic Mice. Res J Pharm Biol Chem Sci. 2018; 9(3): 435-441. 17.

Nakamura T, Girerd S, Jaisser F, Barrera-Chimal J. Mineralocorticoid receptor antagonists in diabetic kidney disease—Mechanistic and therapeutic effects. N L M. 2022; 18(1): 56-70. https://dx.doi.org/10.1038/s41581-021-00490-8

Xie H, Tong Q, Xiang Z, Zhou C, Wan LS, Chen J.Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway. Phytomedicine Plus. 2022;2(1):100152. https://dx.doi.org/10.1016/j.phyplu.2021.100152

Kaur G, Patney V. Progression of CKD and Uremic Symptoms. In Approaches to Chronic Kidney Disease. Springer Cham. 2022: 69-85. https://link.springer.com/chapter/10.1007/978-3-030-83082-3_5

Liu T, Chen J, Ying Y, Shi L, Chen Z. Inhibitory Effect of Gliquidone on Epithelial-to-Mesenchymal-Transition of Renal Tubular Epithelial Cells Under Diabetic Nephropathy Mouse Model. J Biomater Tissue Eng. 2022; 12(1): 71-80. https://dx.doi.org/10.3389%2Ffphar.2020.01136

Keelo RM, Elbe H, Bicer Y, Yigitturk G, Koca O, Karayakali M, et al. Treatment with crocin suppresses diabetic nephropathy progression via modulating TGF-β1 and oxidative stress in an experimental model of pinealectomized diabetic rats. Chem. Biol Interact. 2022Jan5;351:109733. https://dx.doi.org/10.1016/j.cbi.2021.109733

Xu Y, Fu EL, Trevisan M, Jernberg T, Sjolander A Clase C, et al. Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes. Am Heart J .2022; 243: 177-186. https://dx.doi.org/10.1016/j.ahj.2021.09.014

Pagliaro P, Thairi C, Alloatti G, Penna C.. Angiotensin-converting enzyme 2: a key enzyme in key organs. J Cardiol. 2022; 23(1): 1-11. https://dx.doi.org/10.2459/jcm.0000000000001218

Chen S, Redfors B, Serruys PW, Kappetein AP, Crowley A, Yehuda O, et al. Impact of renin-angiotensin system inhibitors after revascularization of patients with left main coronary artery disease. Coron Artery Dis. 2022; 31(1): 37-44. https://dx.doi.org/10.1002/phar.2624

Wysocki J, Ortiz‐Melo DI, Mattocks NK, Xu K, Prescott J, et al. ACE 2 deficiency increases NADPH‐mediated oxidative stress in the kidney. Physiol Rep. 2014; 2(3): e00264. https://dx.doi.org/10.1002%2Fphy2.264

Forthofer RN, Lee ES. Introduction to biostatistics: a guide to design, analysis, and discovery. Elsevier; Academic press, Inc. 2014 May 19. https://books.google.com/books?hl=en&lr=&id=CsvNBQAAQBAJ

Yamamoto Y, Hanai K, Mori T, Yokoyama Y, Yoshida N,et al. Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency. Diabetologia. 2022; 65(1): 234-245. https://dx.doi.org/10.1007/s00125-021-05590-5

Mohammed E, Al Salmi I, Al Riyami D, Khan S, Al Riyami M,et al. Non-Diabetic Kidney Disease in Type 2 Diabetes Mellitus: A Study of 82 Patients and Review of the Literatures. Open J Nephrol. 2022; 12(1):169-186. https://dx.doi.org/10.4236/ojneph.2022.121017

Gluba-Brzózka A, Rysz J, Franczyk B, Banach M. Dyslipidemia and Diabetes. InDiabetes and Kidney Disease. Springer, Cham. 2022: 341-360. https://link.springer.com/chapter/10.1007/978-3-030-86020-2_15.

Kautzky‐Willer A, Kosi L, Lin J, Mihaljevic R. Gender‐based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient‐level pooled data of six randomized controlled trials. Diabetes Obes Metab. 2015; 17(6): 533-540. https://dx.doi.org/10.1007/978-3-030-86020-2

Carlström, M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol.2021;17(9):575-590. https://dx.doi.org/10.1038/s41581-021-00429-z

Ahmed SB, Fisher ND, Hollenberg NK. Gender and the renal nitric oxide synthase system in healthy humans. J Am Soc Nephrol. 2007; 2(5): 926-931. https://dx.doi.org/10.2215/cjn.00110107

Aljack HA. Albumin. Creatinne Ratio as Predictor Markers for Nephropathy in Sudanese Type 2 Diabetic Patients. Sudan Med J. 2018; 6(1). https://dx.doi.org/10.18502/sjms.v14i3.5213

Aljack HA. High sensitive c reactive protein as predictor marker for cardiovascular diseases in Sudanese type 2 diabetic patients. Sudan Med J. 2019; 14(3): 132-142. https://dx.doi.org/10.18502/sjms.v14i3.5213

Mohammed-Ali Z, Lu C, Marway MK, Carlisle RE, Ask K, Lukic D, et al. Endoplasmic reticulum stress inhibition attenuates hypertensive chronic kidney disease through reduction in proteinuria. Sci. Rep. 2017; 7(1): 1-14. https://dx.doi.org/10.1038/srep41572

Otani N, Ouchi M, Misawa K, Hisatome I, Anzai N.Hypouricemia and Urate Transporters. Biomedicines..2022; 10(3): 652. https://dx.doi.org/10.3390/biomedicines10030652

Iocca A, Bardwell A, Schumacher J, Barnes J. Ice-cream substitute for patients with kidney failure. J Ren Nurt. 2022 Jan; 32(2): 207-213. https://dx.doi.org/10.1053/j.jrn.2021.02.002

Ferrario CM, Groban L, Wang H, Sun X, VonCannon JL, Wright KN, Ahmad S.. The renin–angiotensin system biomolecular cascade: a update of newer insights and concepts. Kidney Int Suppl. 2022; 12(1): 36-47. https://dx.doi.org/10.1016/j.kisu.2021.11.002

Nakayama T, Morimoto K, Uchiyama K, Kusahana E, et al. Effects of renin-angiotensin system inhibitors on the incidence of unplanned dialysis. Am J Hypertens . 2022; 45(6): 1018- 27. https://dx.doi.org/10.1038/s41440-022-00877-5

Bovée DM, Uijl E, Severs D, Rubio-Beltrán E, van Veghel R, et al. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease Am. J Physiol Renal Physiol , https://dx.doi.org/10.1152/ajprenal.00603.2020

DeFronzo RA, Bakris GL. Bakris. Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes. Diabetes Obes Metab. 2022; 24: 1197–1205. https://dx.doi.org/10.1111/dom.14696

Golosova D, Levchenko V, Kravtsova O, Palygin O, Staruschenko A. Acute and long-term effects of cannabinoids on hypertension and kidney injury Sci Rep. 2022; 12(1): 1-12. https://dx.doi.org/10.1038/s41598-022-09902-6

Mizdrak M, Kumric M, Kurir T, Bozik J. Emerging Biomarkers for Early Detection of Chronic Kidney Disease. J Pers Med. 2022; 12(4): 548. https://dx.doi.org/10.3390%2Fjpm12040548

Ryuzaki M, Miyashita K, Sato M, Inoue H, Fujii K, et al. Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats. J hypertens. 2022; 40(1): 33-45. https://dx.doi.org/10.1097/hjh.0000000000002974

Arefin S, Hernandez L, Ward L, Stenvinkel P, Kublickiene K. MO069 SARS-COV-2 receptor ACE-2, TMPRSS2 and soluble ACE-2 in patients with end stage kidney disease. Nephrol Dial.2021; 36(1): 078- 005.https://dx.doi.org/10.1093%2Fndt%2Fgfab078.005

Khurana Vatsala, Goswami Binita. Angiotensin converting enzyme (ACE). Clin. Chim. Acta. 2022; 524: 113- 122. https://dx.doi.org/10.1016/j.cca.2021.10.029

Erpolat OP, Senturk E, Saribas S, Pasinlioglu B, Gulbahar O,et al. Angiotensin-converting enzyme inhibitor reduces radiation-induced periprosthetic capsular fibrosis. J Surg Res. 2021; 263: 167-175. https://dx.doi.org/10.1016/j.jss.2021.01.033

Al-Hassnawi AT, Al-Morshidy KA, Al-Harbi NY. Milk Tumor Necrosis Factor Alpha and Interleukin-1Beta Among Toxoplasma gondii-Free and Infected Women. Baghdad Sci J. 2022;19(1): 0001-0006. https://dx.doi.org/10.21123/bsj.2022.19.1.0001

Ma K, Gao W, Xu H, Liang W, Ma G. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. J Renin Angiotensin Aldosterone Syst. 2022 jan 24; 2022. https://dx.doi.org/10.1155/2022/3239057

Nomura H, Kuruppu S, Rajapakse NW.Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy. Front physiol.2022:2497. https://dx.doi.org/10.3389/fphys.2021.813012

Khidhir SM, Mahmud AM, Maulood IM. Association of Endothelin-I and A symmetric Dimethylarginine Levels with Insulin Resistance in Type-2 Diabetes Mellitus Patients. Baghdad Sci J. 2022; 19(1): 0055-0063. https://dx.doi.org/10.21123/bsj.2022.19.1.0055